HOME
ABOUT US
NEWS
PRODUCT

Colloidal Gold Platform
Infectious Disease
Drugs of Abuse
Fertility Health
Cardiology
Oncology
Veterinary Test
Inflammation
Other
Immunofluorescence Platform
Microfluidic Immunofluorescence Analysis System
Lateral Flow Reader
Diagpal Lateral Flow Reader
Diagpal SE Lateral Flow Reader
SERVICE

General Service

Documentation
CAREERS
CONTACT US
CN |SP

HOME
ABOUT US
NEWS
PRODUCT

Colloidal Gold Platform

Infectious Disease

Fertility Health

Drugs of Abuse

Oncology

Cardiology

Veterinary Test

Others

Immunofluorescence Platform

22Infectious Disease

22Fertility Health

22Drugs of Abuse

22Oncology

22Cardiology

22Veterinary Test

22Others

Oncology

33Infectious Disease

33Fertility Health

33Drugs of Abuse

33Oncology

33Cardiology

33Veterinary Test

33Others

Cardiology

44Infectious Disease

44Fertility Health

44Drugs of Abuse

44Oncology

44Cardiology

44Veterinary Test

44Others

Veterinary Test

55Infectious Disease

55Fertility Health

55Drugs of Abuse

55Oncology

55Cardiology

55Veterinary Test

55Others
SERVICE

General Service

Documentation
CAREERS
CONTACT US

News Center

Biotest’s Covid-19 antigen detection reagent obtained CE certification

2020-10-19

<…56789>

Service Hotline

+86-571-89058000

— Follow Us —

ABOUT US: Introduction; Certificates; R&D and Technology

NEWS: News

PRODUCT: FluidicNow Microfluidic Platform; COVID-19 Solution; Infectious Disease; Drug of Abuse; Fertility Health; Cardiology; Oncology; Inflammation; Biochemistry; Instrument; Fluorescence Immunoassay; Veterinary Test; Others

SERVICE: Service Center; Customer Service; Sales Network

CAREERS: Join Us

copyright 2021 Hangzhou Biotest Biotech Co., Ltd 浙ICP备11051548号-1

Power By：A+T

Service hotline

0571-89058000

Follow WeChat

copyright 2021 Hangzhou Biotest Biotech Co., Ltd 浙ICP备11051548号-1

Power By：A+T

Message
Search
Top

Please fill in your contact information